CY1110454T1 - Γονιδιο streptomyces avermitilis που καθοριζει τον λογο αβερμεκτινων β2:β1 - Google Patents
Γονιδιο streptomyces avermitilis που καθοριζει τον λογο αβερμεκτινων β2:β1Info
- Publication number
- CY1110454T1 CY1110454T1 CY20091100467T CY091100467T CY1110454T1 CY 1110454 T1 CY1110454 T1 CY 1110454T1 CY 20091100467 T CY20091100467 T CY 20091100467T CY 091100467 T CY091100467 T CY 091100467T CY 1110454 T1 CY1110454 T1 CY 1110454T1
- Authority
- CY
- Cyprus
- Prior art keywords
- streptomyces avermitilis
- defines
- avermectin
- alter
- ratio
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241001468227 Streptomyces avermitilis Species 0.000 title abstract 2
- 239000005660 Abamectin Substances 0.000 abstract 2
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 241000187747 Streptomyces Species 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35622202P | 2002-02-12 | 2002-02-12 | |
| EP03739390A EP1476539B1 (en) | 2002-02-12 | 2003-01-31 | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110454T1 true CY1110454T1 (el) | 2015-04-29 |
Family
ID=27734621
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100467T CY1110454T1 (el) | 2002-02-12 | 2009-04-27 | Γονιδιο streptomyces avermitilis που καθοριζει τον λογο αβερμεκτινων β2:β1 |
| CY20111101193T CY1112491T1 (el) | 2002-02-12 | 2011-12-02 | Γονιδιο streptomyces avermitilis που ελεγχει την αναλογια αβερμεκτινων β2:β1 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111101193T CY1112491T1 (el) | 2002-02-12 | 2011-12-02 | Γονιδιο streptomyces avermitilis που ελεγχει την αναλογια αβερμεκτινων β2:β1 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7388085B2 (enExample) |
| EP (2) | EP2050815B1 (enExample) |
| JP (1) | JP2005517406A (enExample) |
| KR (1) | KR100718378B1 (enExample) |
| CN (2) | CN1630712B (enExample) |
| AR (1) | AR038405A1 (enExample) |
| AT (2) | ATE530645T1 (enExample) |
| AU (1) | AU2003245052B2 (enExample) |
| BR (1) | BRPI0307620B8 (enExample) |
| CA (1) | CA2475214C (enExample) |
| CY (2) | CY1110454T1 (enExample) |
| DE (1) | DE60326824D1 (enExample) |
| DK (2) | DK2050815T3 (enExample) |
| ES (2) | ES2321827T3 (enExample) |
| IL (3) | IL162866A0 (enExample) |
| ME (1) | ME00472B (enExample) |
| MX (1) | MXPA04007777A (enExample) |
| PL (1) | PL211693B1 (enExample) |
| PT (2) | PT1476539E (enExample) |
| RS (1) | RS50813B (enExample) |
| RU (1) | RU2293117C2 (enExample) |
| SI (2) | SI2050815T1 (enExample) |
| TW (1) | TWI341330B (enExample) |
| WO (1) | WO2003068955A2 (enExample) |
| ZA (1) | ZA200405345B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2321827T3 (es) * | 2002-02-12 | 2009-06-12 | Pfizer Products Inc. | Gen de streptomyces avermitilis que rige la relacion de avermectinas b2-b1. |
| CN102241750B (zh) * | 2010-05-14 | 2014-05-28 | 中国科学院微生物研究所 | 一种生产阿维菌素的基因工程方法及其专用菌株 |
| CN102093997B (zh) * | 2010-12-01 | 2013-03-13 | 中国科学院上海有机化学研究所 | 一种改造除虫链霉菌产生多拉菌素的方法 |
| CN109576196B (zh) * | 2019-01-25 | 2022-01-04 | 北大方正集团有限公司 | 一种生产多拉菌素的发酵培养基及多拉菌素的生产方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4429042A (en) | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| IN167980B (enExample) | 1987-01-23 | 1991-01-19 | Pfizer | |
| US5252474A (en) | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| CZ287404B6 (en) * | 1993-10-05 | 2000-11-15 | Pfizer | Process for preparing doramectin |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6248579B1 (en) * | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| AU752343C (en) * | 1998-02-13 | 2005-11-03 | Pfizer Products Inc. | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| RU2156301C2 (ru) * | 1998-06-09 | 2000-09-20 | Мосин Владимир Александрович | Штамм актиномицета streptomyces avermitilis ссм 4697 - продуцент авермектинов |
| US6197591B1 (en) | 1998-09-14 | 2001-03-06 | Pfizer Inc. | Streptomyces avermitilis regulatory genes for increased avermectin production |
| JP3884651B2 (ja) * | 1999-08-12 | 2007-02-21 | ファイザー・プロダクツ・インク | Ｂ２アベルメクチン：ｂ１アベルメクチンの比を指示するストレプトミセス・アベルミティリス遺伝子 |
| NZ517694A (en) | 1999-08-13 | 2005-03-24 | Vertex Pharma | Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| ES2321827T3 (es) * | 2002-02-12 | 2009-06-12 | Pfizer Products Inc. | Gen de streptomyces avermitilis que rige la relacion de avermectinas b2-b1. |
-
2003
- 2003-01-31 ES ES03739390T patent/ES2321827T3/es not_active Expired - Lifetime
- 2003-01-31 ES ES09150098T patent/ES2373629T3/es not_active Expired - Lifetime
- 2003-01-31 DE DE60326824T patent/DE60326824D1/de not_active Expired - Lifetime
- 2003-01-31 AU AU2003245052A patent/AU2003245052B2/en not_active Expired
- 2003-01-31 IL IL16286603A patent/IL162866A0/xx unknown
- 2003-01-31 SI SI200332087T patent/SI2050815T1/sl unknown
- 2003-01-31 PL PL371320A patent/PL211693B1/pl unknown
- 2003-01-31 CA CA2475214A patent/CA2475214C/en not_active Expired - Lifetime
- 2003-01-31 RU RU2004124521/13A patent/RU2293117C2/ru active
- 2003-01-31 EP EP09150098A patent/EP2050815B1/en not_active Expired - Lifetime
- 2003-01-31 ME MEP-2008-730A patent/ME00472B/me unknown
- 2003-01-31 EP EP03739390A patent/EP1476539B1/en not_active Expired - Lifetime
- 2003-01-31 WO PCT/IB2003/000348 patent/WO2003068955A2/en not_active Ceased
- 2003-01-31 DK DK09150098.3T patent/DK2050815T3/da active
- 2003-01-31 BR BRPI0307620A patent/BRPI0307620B8/pt active IP Right Grant
- 2003-01-31 CN CN038037416A patent/CN1630712B/zh not_active Expired - Lifetime
- 2003-01-31 AT AT09150098T patent/ATE530645T1/de active
- 2003-01-31 DK DK03739390T patent/DK1476539T3/da active
- 2003-01-31 RS YUP-700/04A patent/RS50813B/sr unknown
- 2003-01-31 PT PT03739390T patent/PT1476539E/pt unknown
- 2003-01-31 SI SI200331553T patent/SI1476539T1/sl unknown
- 2003-01-31 CN CN2011102082591A patent/CN102392028B/zh not_active Expired - Lifetime
- 2003-01-31 KR KR1020047012437A patent/KR100718378B1/ko not_active Expired - Lifetime
- 2003-01-31 AT AT03739390T patent/ATE426659T1/de active
- 2003-01-31 JP JP2003568070A patent/JP2005517406A/ja active Pending
- 2003-01-31 MX MXPA04007777A patent/MXPA04007777A/es active IP Right Grant
- 2003-01-31 PT PT09150098T patent/PT2050815E/pt unknown
- 2003-02-10 TW TW092102676A patent/TWI341330B/zh not_active IP Right Cessation
- 2003-02-10 US US10/361,376 patent/US7388085B2/en not_active Expired - Lifetime
- 2003-02-10 AR ARP030100408A patent/AR038405A1/es active IP Right Grant
-
2004
- 2004-07-05 IL IL162866A patent/IL162866A/en active IP Right Grant
- 2004-07-05 ZA ZA200405345A patent/ZA200405345B/xx unknown
-
2008
- 2008-04-23 US US12/107,949 patent/US8008078B2/en not_active Expired - Fee Related
- 2008-06-22 IL IL192371A patent/IL192371A/en active IP Right Grant
-
2009
- 2009-04-27 CY CY20091100467T patent/CY1110454T1/el unknown
-
2011
- 2011-12-02 CY CY20111101193T patent/CY1112491T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gupta et al. | Phylogenomic analyses and molecular signatures for the class Halobacteria and its two major clades: a proposal for division of the class Halobacteria into an emended order Halobacteriales and two new orders, Haloferacales ord. nov. and Natrialbales ord. nov., containing the novel families Haloferacaceae fam. nov. and Natrialbaceae fam. nov. | |
| ES2421596T3 (es) | Desaminasa inducida por activación (AID) | |
| CY1106408T1 (el) | Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης | |
| Najafi et al. | Bacterial mutation; types, mechanisms and mutant detection methods: a review | |
| CY1110454T1 (el) | Γονιδιο streptomyces avermitilis που καθοριζει τον λογο αβερμεκτινων β2:β1 | |
| WO2005058945A3 (de) | Genvarianten die für proteine aus dem stoffwechselweg von feinchemikalien kodieren | |
| DE60336124D1 (de) | Gen-targeting mit replizierenden dna-molekülen | |
| CY1105778T1 (el) | Γονιδιο του streptomyces avermitilis που κατευθυνει την αναλογια των αβepμεκτινων β2:β1 | |
| CO5070698A1 (es) | Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2:b1 | |
| UY26287A1 (es) | Gen de streptomyces avermitilis que que dirige la relación de avermectinas b2:b1 | |
| ATE486967T1 (de) | Herstellung von thiamin durch fermentation | |
| Jestin et al. | Chain termination codons and polymerase-induced frameshift mutations | |
| BR0110128A (pt) | Mutante de bactéria láctica superprodutora de exopolissacarìdeos, utilização do mesmo e ácido nucleico codificando uma alfa-fosfoglucomutase | |
| Ivanov | The binary code for protein—nucleic acid recognition with repulsive guanine: Application to tRNA case | |
| Hardy et al. | The tRNA epitranscriptomic landscape and RNA modification enzymes in Vibrio cholerae | |
| EP1576136A4 (en) | METHOD FOR IDENTIFYING ANTIMICROBIAL COMPOUNDS | |
| Zhang et al. | Prolonged Starvation Drives Epigenetic Remodeling: Insights from DNA Methylation Profiling in the Aquatic Pathogen Flavobacterium columnare | |
| Damm et al. | 6S-1 pRNA 9-mers are a prominent length species during outgrowth of Bacillus subtilis cells from extended stationary phase | |
| WO2021243218A3 (en) | Differential knockout of a heterozygous allele of samd9 | |
| Guo | Translesion synthesis and mutations: On the mutagenic properties of the two DNA lesions, 8-oxo-G and Pt-GG, and the functions of Y-family DNA polymerases and Rev3L on the bypass of each of the DNA lesions in mammalian cells | |
| WO2007044839A3 (en) | Glutamate 2,3-aminomutases and methods of use thereof | |
| JP2006296305A5 (enExample) |